Senior insider sale
General Counsel at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$807.2K
33.02K shares
What this filing means
HANSON KRISTOPHER plans to sell 33.02K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $807.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001974158-26-000102
Officer· General Counsel
Since Feb 2026
33.02K
Shares to sell
$807.2K
Approx. market value
16.51K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Vested RSU
N/A
7/30/2023
16.51KTotal acquired16.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/30/2023 | Vested RSU N/A | 16.51K | — |
| Total | 16.51K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.13K
Market value
$42.8K
7/17/2026
—Completed
Units to sell
8.12K
Market value
$298.6K
7/16/2026
—Completed
Units to sell
7.26K
Market value
$266.3K
7/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.51K
Market value
$199.4K
9/16/2026
Total
Units
33.02K
Value
$807.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/17/2026 | 1.13K | $42.8K | — | Completed |
7/16/2026 | 8.12K | $298.6K | — | Completed |
7/15/2026 | 7.26K | $266.3K | — | Completed |
| Planned — Approximate Date | ||||
9/16/2026 | 16.51K | $199.4K | NASDAQ | Planned |
| Total | 33.02K | $807.2K | ||